» Articles » PMID: 38005352

Research Progress on Natural Plant Molecules in Regulating the Blood-Brain Barrier in Alzheimer's Disease

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2023 Nov 25
PMID 38005352
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder. With the aging population and the continuous development of risk factors associated with AD, it will impose a significant burden on individuals, families, and society. Currently, commonly used therapeutic drugs such as Cholinesterase inhibitors, N-methyl-D-aspartate antagonists, and multiple AD pathology removal drugs have been shown to have beneficial effects on certain pathological conditions of AD. However, their clinical efficacy is minimal and they are associated with certain adverse reactions. Furthermore, the underlying pathological mechanism of AD remains unclear, posing a challenge for drug development. In contrast, natural plant molecules, widely available, offer multiple targeting pathways and demonstrate inherent advantages in modifying the typical pathologic features of AD by influencing the blood-brain barrier (BBB). We provide a comprehensive review of recent in vivo and in vitro studies on natural plant molecules that impact the BBB in the treatment of AD. Additionally, we analyze their specific mechanisms to offer novel insights for the development of safe and effective targeted drugs as well as guidance for experimental research and the clinical application of drugs for the prevention and treatment of AD.

Citing Articles

Bromelain Protects Against PTZ-Induced Glial Damage and Inflammation: An In Vitro and In Silico Study.

Joha Z, Basgoz N, Ozgur A, Taskiran A Cell Biochem Biophys. 2025; .

PMID: 40000586 DOI: 10.1007/s12013-025-01703-8.


Composite of KLVFF-Transthyretin-Penetratin and Manganese Dioxide Nanoclusters: A Multifunctional Agent against Alzheimer's β-Amyloid Fibrillogenesis.

Lan H, Wang Y, Liu W, Dong X, Sun Y Molecules. 2024; 29(6).

PMID: 38543041 PMC: 10975269. DOI: 10.3390/molecules29061405.


The Inhibition of Mitogen-Activated Protein Kinases (MAPKs) and NF-κB Underlies the Neuroprotective Capacity of a Cinnamon/Curcumin/Turmeric Spice Blend in Aβ-Exposed THP-1 Cells.

Maugeri A, Russo C, Patane G, Barreca D, Mandalari G, Navarra M Molecules. 2023; 28(24).

PMID: 38138438 PMC: 10745857. DOI: 10.3390/molecules28247949.

References
1.
Yao Y, Ren Z, Yang R, Mei Y, Dai Y, Cheng Q . Salidroside reduces neuropathology in Alzheimer's disease models by targeting NRF2/SIRT3 pathway. Cell Biosci. 2022; 12(1):180. PMC: 9636768. DOI: 10.1186/s13578-022-00918-z. View

2.
Bhat A, Dar K, Anees S, Zargar M, Masood A, Sofi M . Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015; 74:101-10. DOI: 10.1016/j.biopha.2015.07.025. View

3.
Hong J, Kang J, Kim D, Baik S, Kim K, Shanta S . Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer's disease. J Lipid Res. 2015; 57(1):36-45. PMC: 4689334. DOI: 10.1194/jlr.M057869. View

4.
Ding H, Wang H, Zhao Y, Sun D, Zhai X . Protective Effects of Baicalin on Aβ₁₋₄₂-Induced Learning and Memory Deficit, Oxidative Stress, and Apoptosis in Rat. Cell Mol Neurobiol. 2015; 35(5):623-32. PMC: 11486265. DOI: 10.1007/s10571-015-0156-z. View

5.
Liu Z, Wang Z, Zhu Z, Hong J, Cui L, Hao Y . Crocetin Regulates Functions of Neural Stem Cells to Generate New Neurons for Cerebral Ischemia Recovery. Adv Healthc Mater. 2023; 12(20):e2203132. DOI: 10.1002/adhm.202203132. View